Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB

CompletedOBSERVATIONAL
Enrollment

551

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Bladder Cancer
Trial Locations (24)

1090

AKH, Klinik für Urologie der Universität Wien, Vienna

14642

URMC, Rochester

19107

Thomas Jefferson Medical College, Department of Neurology, Philadelphia

30322

The Emory Clinic, Dept of Urology, Atlanta

32608

V.A. Medical Center, Gainesville

33028

South Florida Clinical Research Center, Inc., Pembroke Pines

33136

University of Miami School of Medicine, Miami

35392

University Clinic of Giessen, Department of Urology, Giessen

55905

Urologic Clinical Research Unit, Gonda 7102, Mayo Clinic Rochester, Rochester

72076

Universitätsklinik Tuebingen, Universitätsklinik für Urologie, Tübingen

81377

Klinikum der Universität München-Großhardern, Urologische Klinik und Poliklinik, München

82152

Urologische Klinik München-Planegg, Planegg

93053

Akadem. Lehrkrankenhaus der Uni Regensburg, Klinik für Urologie, Regensburg

94305-5820

Stanford Cancer Center, Department of Urology, Stanford

02118

Boston University School of Medicine, Boston

07601

Hackensack University Medical Center, Hackensack

10029-6574

Mount Sinai Medical Center, Department of Urology, New York

37232-2765

Vanderbilt University Medical Center, Department of Urologic Surgery, Nashville

77030-2726

Baylor College of Medicine, Scott Department of Urology, Houston

77030-4009

The University of Texas MD Anderson cancer center, Houston

K7L 2V7

Kingston General Hospital, Kingston

G1R 2J6

CHUQ Hotel-Dieu de Quebec, Québec

1105 AZ

Department of Urology, Academic Medical Center, University of Amsterdam, Amsterdam

6500 HB

Department of Urology, UMC St. Radboud, Nijmegen

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Photocure

INDUSTRY